BRIEF published on 05/06/2025 at 18:13, 1 year 1 month ago Financial Performance of LNA Santé in the First Quarter of 2025 Organic Growth International Expansion Turnover Real Estate Sales Outpatient Care
REGULATED PRESS RELEASE published on 05/06/2025 at 18:10, 1 year 1 month ago LNA SANTE : Q1 2025 LNA Santé reports 8.9% organic growth in operating revenue reaching €209.7m for Q1 2025, driven by outpatient care. Real estate sales surge by 644.7% LNA Santé Organic Growth Real Estate Sales Operating Revenue Outpatient Care
REGULATED PRESS RELEASE published on 05/06/2025 at 18:08, 1 year 1 month ago LNA SANTE : Chiffre d'affaires du 1er trimestre 2025 LNA Santé affiche une croissance solide au T1 2025, portée par le développement des soins ambulatoires et la dynamique des ventes immobilières Croissance LNA Santé Ventes Immobilières Soins Ambulatoires T1 2025
BRIEF published on 05/05/2025 at 16:50, 1 year 1 month ago LNA Santé : Répartition du Capital et Droits de Vote au 30 Avril 2025 Capital Société Générale LNA Santé Droits De Vote Franchissement De Seuil
BRIEF published on 05/05/2025 at 16:50, 1 year 1 month ago LNA Santé: Distribution of Capital and Voting Rights as of April 30, 2025 Voting Rights Capital Société Générale Threshold Crossing LNA Health
REGULATED PRESS RELEASE published on 05/05/2025 at 16:45, 1 year 1 month ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 30/04/2025 Déclaration de répartition de capital et des droits de vote de Société Générale au 30/04/2025 selon l'article 223-16 de l'AMF Société Générale LNA Santé Droits De Vote AMF Répartition De Capital
BRIEF published on 04/29/2025 at 19:07, 1 year 1 month ago LNA Santé : Publication du Document d'Enregistrement Universel 2024 Rachat D'actions LNA Santé AMF Document D'enregistrement Comptes 2024
BRIEF published on 04/29/2025 at 19:07, 1 year 1 month ago LNA Santé: Publication of the 2024 Universal Registration Document Share Buyback AMF LNA Health Registration Document 2024 Accounts
REGULATED PRESS RELEASE published on 04/29/2025 at 19:02, 1 year 1 month ago LNA SANTE : Mise à disposition du document d'enregistrement universel 2024 LNA Santé dépose son document d'enregistrement universel 2024 auprès de l'AMF, consultable sur leur site web. Informations financières et gouvernance incluses Gouvernance LNA Santé AMF Finance Document D'Enregistrement Universel
BRIEF published on 04/02/2025 at 16:23, 1 year 2 months ago Répartition Capitale et Droits de Vote chez LNA Santé au 31 Mars 2025 Capital LNA Santé Droits De Vote Franchissements De Seuils Répartition
Published on 06/26/2026 at 13:00, 9 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 11 hours 29 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 39 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 39 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 12:18, 50 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 39 minutes ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 1 hour 54 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 2 hours 3 minutes ago Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 07:00, 6 hours 9 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 9 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 24 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 39 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
